The US Federal Trade Commission has been highly successful in blocking mergers in court over the past several years, but it recently lost its challenge to the Evonik/PeroxyChem merger. Jenn Mellott speaks with Eric Mahr, Andrew Ewalt, and Laura Onken, members of the Freshfields antitrust team who worked on the litigation, about the case and what businesses should take away from this significant win against the FTC.